Ship- A Randomized, Placebo-Controlled Pilot Study Of Sulfasalazine For The Treatment Of Primary Sclerosing Cholangitis
Posted Date: May 23, 2019
- Investigator: Kenneth Sherman
- Type of Study: Drug
We are doing this research study to find out if sulfasalazine can help people with Primary Sclerosing Cholangitis (PSC). Sulfasalazine is approved by the FDA to treat Ulcerative Colitis (UC) and Crohn’s disease (CD), but Sulfasalazine is not approved by the FDA to treat PSC.
To Eligible For This Study Patients Must Have Been Diagnosed With Psc And Inflamatory Bowel Disease (Either Chron's Or Ulcerative Colitis).
For More Information: